title: The Di Bella multitherapy trial. Criticism ignores standard methodology of cancer treatments.
authors.forename: R
authors.initials: R
authors.lastname: Raschetti
authors.forename: D
authors.initials: D
authors.lastname: Greco
authors.forename: F
authors.initials: F
authors.lastname: Menniti-Ippolito
authors.forename: S
authors.initials: S
authors.lastname: Spila-Alegiani
authors.forename: G
authors.initials: G
authors.lastname: Benagiano
authors.forename: P
authors.initials: P
authors.lastname: Bruzzi
mesh_terms: D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D000529:Complementary Therapies; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic